pulmoПульмонологияPULMONOLOGIYA0869-01892541-9617Scientific and Practical Journal “PULMONOLOGIYA” LLCpulmo-2840Research ArticleЛЕКЦИИLECTIONS100 лет заместительной панкреатической терапии; история создания препарата Pankreon (Панкреон)A hundred years of replacing pancreatic therapy; the history of Pankreon developmentRudmannM. A.RudmannM. A.
Hannover
Отдел международного сотрудничества; Solvay Pharmaceuticals Gm bHGermany20013009200103120124Copyright © Rudmann M.A., 20012001Rudmann M.A.Rudmann M.A.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://journal.pulmonology.ru/pulm/article/view/2840
.
.
ReferencesKuhlmann Н. In: Rudmann M.A., ed. The magic potions in the belly gland. Hannover: Solvay Pharmaceuticals GmbH; 2000.Kuhlmann Н. In: Rudmann M.A., ed. The magic potions in the belly gland. Hannover: Solvay Pharmaceuticals GmbH; 2000.Rapaille M. Solvay. Ein Mann und sein Werk. Brussels: Didier Hatier; 1991.Rapaille M. Solvay. Ein Mann und sein Werk. Brussels: Didier Hatier; 1991.Gockel M. Uber Erfolge mit ’Pankreon’, einem neuen, gegen Magensaft widerstandsfähigen Pankreaspraparat. Cbl. Stoffwechsel- и. Verdauungskrankheit. 1900; 11: 251—256.Gockel M. Uber Erfolge mit ’Pankreon’, einem neuen, gegen Magensaft widerstandsfähigen Pankreaspraparat. Cbl. Stoffwechsel- и. Verdauungskrankheit. 1900; 11: 251—256.Von Noorden C. Zur Diagnostik der Pankreaserkrankungen. Klin.-ther. Wschr. 1908; 35: 929—934.Von Noorden C. Zur Diagnostik der Pankreaserkrankungen. Klin.-ther. Wschr. 1908; 35: 929—934.Peschke G. Solvay Pharmaceuticals GmbH (data on file), 2000.Peschke G. Solvay Pharmaceuticals GmbH (data on file), 2000.Smyth R.L. et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346: 1247—1251.Smyth R.L. et al. Fibrosing colonopathy in cystic fibrosis: results of a case-control study. Lancet 1995; 346: 1247—1251.Prescott P., Bakowski M.T. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer. Pharmacoepidemiol. Drug Saf. 1999; 8: 377—384.Prescott P., Bakowski M.T. Pathogenesis of fibrosing colonopathy: the role of methacrylic acid copolymer. Pharmacoepidemiol. Drug Saf. 1999; 8: 377—384.Bansi D.S. et al. Fibrosing colonopathy in an adult owing to overuse of pancreatic enzyme supplements. Gut 2000; 46: 283—285.Bansi D.S. et al. Fibrosing colonopathy in an adult owing to overuse of pancreatic enzyme supplements. Gut 2000; 46: 283—285.Littlewood J.M., Wolfe S.P. Control of malabsorption in cystic fibrosis. Paediatr. Drugs 2000; 3: 205—222.Littlewood J.M., Wolfe S.P. Control of malabsorption in cystic fibrosis. Paediatr. Drugs 2000; 3: 205—222.Apte M.V. et al. Chronic pancreatitis: complications and management. J. Clin. Gastroenterol. 1999; 29: 225—240.Apte M.V. et al. Chronic pancreatitis: complications and management. J. Clin. Gastroenterol. 1999; 29: 225—240.Mohan V. et al. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int. J. Pancreatol. 1998; 24: 19—22.Mohan V. et al. Oral pancreatic enzyme therapy in the control of diabetes mellitus in tropical calculous pancreatitis. Int. J. Pancreatol. 1998; 24: 19—22.Van Hoozen C.M. et al. Efficacy of enzyme supplementation after surgery for chronic pancreatitis. Pancreas 1997; 14: 174—180.Van Hoozen C.M. et al. Efficacy of enzyme supplementation after surgery for chronic pancreatitis. Pancreas 1997; 14: 174—180.Neoptolemos J.P. et al. T rea tm en t of pancreatic exocrine insufficiency after pancreatic resection. Int. J. Pancreatol. 1999; 25: 171—180.Neoptolemos J.P. et al. T rea tm en t of pancreatic exocrine insufficiency after pancreatic resection. Int. J. Pancreatol. 1999; 25: 171—180.Bragelmann R. et al. The effect of pancreatic enzyme supplementation in patients with steatorhoea after gastrectomy. Eur. J. Gastroenterol. Hepatol. 1999; 11: 231—237.Bragelmann R. et al. The effect of pancreatic enzyme supplementation in patients with steatorhoea after gastrectomy. Eur. J. Gastroenterol. Hepatol. 1999; 11: 231—237.Kitagawa M. et al. Evaluating exocrine function te s ts for diagnosing chronic pancreatitis. Pancreas 1997; 15: 402—408.Kitagawa M. et al. Evaluating exocrine function te s ts for diagnosing chronic pancreatitis. Pancreas 1997; 15: 402—408.Rathmann W. et al. Pancreatic exocrine insufficiency and type 2 diabetes are strongly associated. Diabetologia 1999; 42 (suppl.lA): 297.Rathmann W. et al. Pancreatic exocrine insufficiency and type 2 diabetes are strongly associated. Diabetologia 1999; 42 (suppl.lA): 297.George D.E. et al. Comparison of two pancreatic enzyme supplements in pa tien ts with cystic fibrosis. Adv. Ther. 1990; 7: 109—118.George D.E. et al. Comparison of two pancreatic enzyme supplements in pa tien ts with cystic fibrosis. Adv. Ther. 1990; 7: 109—118.Friesen C., Prestidge С. Comparison of a high-strength pancreatic enzyme preparation and a standard-strength preparation in cystic fibrosis. Ibid. 1995; 12: 236—244.Friesen C., Prestidge С. Comparison of a high-strength pancreatic enzyme preparation and a standard-strength preparation in cystic fibrosis. Ibid. 1995; 12: 236—244.Braden B. et al. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein® breath test: evidence of normalized fat assimilation with high dose pancreatin therapy. Z. Gastroenterol. 1997; 35: 123—129.Braden B. et al. Monitoring pancreatin supplementation in cystic fibrosis patients with the 13C-Hiolein® breath test: evidence of normalized fat assimilation with high dose pancreatin therapy. Z. Gastroenterol. 1997; 35: 123—129.Lankisch P.G. Conservative trea tm en t of chronic pancreatitis. Digestion 1987; 37 (supp l.l): 47—55.Lankisch P.G. Conservative trea tm en t of chronic pancreatitis. Digestion 1987; 37 (supp l.l): 47—55.Vyas H. et al. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis: A controlled study. Eur. J. Pediatr. 1990; 149: 241—243.Vyas H. et al. A comparison of enteric coated microspheres with enteric coated tablet pancreatic enzyme preparations in cystic fibrosis: A controlled study. Eur. J. Pediatr. 1990; 149: 241—243.Layer P., Holtmann G. Pancreatic enzymes in chronic pancreatitis. Int. J. Pancreatol. 1994; 15: 1—11.Layer P., Holtmann G. Pancreatic enzymes in chronic pancreatitis. Int. J. Pancreatol. 1994; 15: 1—11.Meyer J.H. et al. Human postprandial g astric emptying of 1—3 millimeter spheres. Gastroenterology 1988; 94: 1315—1325.Meyer J.H. et al. Human postprandial g astric emptying of 1—3 millimeter spheres. Gastroenterology 1988; 94: 1315—1325.Kuhnelt P., Mundlos S., Adler G. Einfluss der Pelletgosse eines Pankreasenzympraparates auf die duodenale lipolytische Aktivität. Z. Gastroenterol. 1991; 29: 417—421.Kuhnelt P., Mundlos S., Adler G. Einfluss der Pelletgosse eines Pankreasenzympraparates auf die duodenale lipolytische Aktivität. Z. Gastroenterol. 1991; 29: 417—421.Mundlos S., Kuhnelt P., Adler G. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 1991; 31: 1324—1328.Mundlos S., Kuhnelt P., Adler G. Monitoring enzyme replacement treatment in exocrine pancreatic insufficiency using the cholesteryl octanoate breath test. Gut 1991; 31: 1324—1328.Layer P. et al. Enzyme pellet size and luminal n u trient digestion in pancreatic insufficiency. Digestion 1992; 52: 100.Layer P. et al. Enzyme pellet size and luminal n u trient digestion in pancreatic insufficiency. Digestion 1992; 52: 100.Norregard P. et al. Gastric emptying of pancreatin granules and dietary lipids in pancreatic insufficiency. Aliment. Pharmacol. Ther. 1996; 10: 427—432.Norregard P. et al. Gastric emptying of pancreatin granules and dietary lipids in pancreatic insufficiency. Aliment. Pharmacol. Ther. 1996; 10: 427—432.Lippold B.C. What is the ideal size for enteric-coated pancreatic preparations? Drugs made in Germany 1998; 41: 52—56.Lippold B.C. What is the ideal size for enteric-coated pancreatic preparations? Drugs made in Germany 1998; 41: 52—56.Beverley D.W. et al. Comparison of four different pancreatic extracts in cystic fibrosis. Arch. Dis. Child. 1987; 62: 564—568.Beverley D.W. et al. Comparison of four different pancreatic extracts in cystic fibrosis. Arch. Dis. Child. 1987; 62: 564—568.Stead R.J. et al. Treatment of ste ato rrh o ea in cystic fibrosis: A comparison of enteric coated microspheres of pancreatin versus non-enteric coated pancreatin and adjuvant cimetidine. Aliment. Pharmacol. Ther. 1988; 2: 471—482.Stead R.J. et al. Treatment of ste ato rrh o ea in cystic fibrosis: A comparison of enteric coated microspheres of pancreatin versus non-enteric coated pancreatin and adjuvant cimetidine. Aliment. Pharmacol. Ther. 1988; 2: 471—482.Whitehead A.M. Stu d y to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations. Pharm. Weekbl. (Sei.) 1988; 10: 12—16.Whitehead A.M. Stu d y to compare the enzyme activity, acid resistance and dissolution characteristics of currently available pancreatic enzyme preparations. Pharm. Weekbl. (Sei.) 1988; 10: 12—16.Atkinson S.N. A comparative study of enzyme activity, acid resistance and dissolution characteris tics of four enteric coated microsphere preparations of pancreatin. Eur. J. Clin. Res. 1991; 1: 37—45.Atkinson S.N. A comparative study of enzyme activity, acid resistance and dissolution characteris tics of four enteric coated microsphere preparations of pancreatin. Eur. J. Clin. Res. 1991; 1: 37—45.Huwel S., Behrens R., Spener F. Pankreasenzyme: Präparate im Vergleich. Pharm. Ztg. 1996; 37: 33—42.Huwel S., Behrens R., Spener F. Pankreasenzyme: Präparate im Vergleich. Pharm. Ztg. 1996; 37: 33—42.
The authors declare that there are no conflicts of interest present.